Journal
CELL REPORTS
Volume 26, Issue 9, Pages 2257-+Publisher
CELL PRESS
DOI: 10.1016/j.celrep.2019.01.106
Keywords
-
Categories
Funding
- Ministerio de Economia y Competitividad [PI15/00107, SAF2016-76815, SAF2017-90794-REDT, BES-2014-068618]
- Fundacio La Marato de TV3 [534/C/2016]
- CAM Atraccion de Talento program
- VIB-Marie Curie omics program
- Marie Curie CIG
- FWO Odysseus II
- Eugene Yourassowsky Schenking
- KU Leuven Methusalem
- University of Castilla-La Mancha (UCLM)
- Ministerio de Educacion y Ciencia [SAF2015-64215-R]
- Fundacion Leticia Castillejo Castillo
- FWO Research Grants
Ask authors/readers for more resources
Cellular aspartate drives cancer cell proliferation, but signaling pathways that rewire aspartate biosynthesis to control cell growth remain largely unknown. Hypoxia-inducible factor-1 alpha (HIF1 alpha) can suppress tumor cell proliferation. Here, we discovered that HIF1 alpha acts as a direct repressor of aspartate biosynthesis involving the suppression of several key aspartate-producing proteins, including cytosolic glutamic-oxaloacetic transaminase-1 (GOT1) and mitochondrial GOT2. Accordingly, HIF1 alpha suppresses aspartate production from both glutamine oxidation as well as the glutamine reductive pathway. Strikingly, the addition of aspartate to the culture medium is sufficient to relieve HIF1 alpha-dependent repression of tumor cell proliferation. Furthermore, these key aspartate-producing players are specifically repressed in VHL-deficient human renal carcinomas, a paradigmatic tumor type in which HIF1 alpha acts as a tumor suppressor, high-lighting the in vivo relevance of these findings. In conclusion, we show that HIF1 alpha inhibits cytosolic and mitochondrial aspartate biosynthesis and that this mechanism is the molecular basis for HIF1 alpha tumor suppressor activity.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available